The Delaware Supreme Court overturned one section of a wide-ranging ruling that held the pharmaceutical giant liable for its allegedly lackluster efforts to bring the medical devices to market. But the court upheld multiple key portions of the decision, which said J&J “almost immediately” breached contract provisions entitling former Auris investors to contingent deferred payments known as “earnouts.”
Although ...